Pfizer tests medicines for early treatment of COVID-19
The American pharmaceutical company Pfizer has begun the first phase of clinical trials of an oral pre-oral drug for outpatient use at the first symptoms of coronavirus infection COVID-19. Experts are also studying the possibility of using a similar drug for intravenous administration in a hospital setting. According to Medportal.ru, the drug, codenamed PF-07321332, is…